Stacy De Serio
About Stacy De Serio
Stacy De Serio is a Pharmacovigilance Scientist at Bristol Myers Squibb with over 20 years of experience in pharmacovigilance and drug safety.
Title and Current Position
Stacy De Serio is a Pharmacovigilance Scientist currently working at Bristol Myers Squibb in Summit, New Jersey. In her role, she is responsible for the safety monitoring and risk management of pharmaceutical products, ensuring that any adverse events are properly documented and investigated.
Previous Roles at Celgene
Stacy De Serio has a substantial history with Celgene, where she worked from 2008 to 2021. She started as a Drug Safety Specialist from 2008 to 2015, followed by roles as Scientist, Trials Safety from 2015 to 2018, and later as Manager, Safety Science from 2018 to 2021. Her work at Celgene involved various aspects of drug safety and trials, spanning over 13 years.
Experience at Memorial Sloan Kettering Cancer Center
Before joining Celgene, Stacy De Serio held several roles at Memorial Sloan Kettering Cancer Center in New York, working as a Research Study Assistant from 2000 to 2002, Serious Adverse Event Coordinator from 2002 to 2003, and Manager, Institutional Serious Adverse Event from 2003 to 2005. These positions provided her with extensive experience in managing serious adverse events in clinical settings.
Educational Background
Stacy De Serio holds a Master of Public Administration (MPA) in Health/Health Care Administration/Management from the NYU Robert F. Wagner Graduate School of Public Service, completed from 1999 to 2001. She also earned a Bachelor of Arts (BA) in Medical Anthropology from the University of Pennsylvania, where she studied from 1993 to 1997. This educational background has equipped her with a profound understanding of public health and medical anthropology, complementing her extensive experience in pharmacovigilance.
Early Career and Research Experience
Stacy De Serio began her career as a Research Assistant at the Children's Hospital of Philadelphia in 1996, a role she held for eight months. This early experience laid the foundation for her subsequent work in clinical and pharmaceutical research. Her role involved assisting in various studies, contributing to the development of her expertise in drug safety and clinical research.